These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1997173)

  • 41. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
    Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concepts for treatment of micrometastases developed in murine systems.
    Schabel FM
    AJR Am J Roentgenol; 1976 Mar; 126(3):500-11. PubMed ID: 178196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules.
    Grdina DJ
    Br J Cancer; 1982 Mar; 45(3):438-46. PubMed ID: 7073937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bacteriocins as cytotoxic agents in experimental neoplasms: considerations on the role of possible contaminants].
    Fumarola D; Bello P; Palma R; Miragliotta G; Panaro A
    G Batteriol Virol Immunol; 1977; 70(1-6):87-93. PubMed ID: 614148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intraperitoneal ATP on tumor growth and bone marrow radiation tolerance.
    Froio J; Abraham EH; Soni R; Epstein A; Okunieff P
    Acta Oncol; 1995; 34(3):419-22. PubMed ID: 7779434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic effect of adriamycin in vivo on synchronized murine fibrosarcoma cells.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1305-8. PubMed ID: 528282
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor-host interactions accompanying the growth of the G:5:113 fibrosarcoma in the mouse: possibilities for a new therapeutic approach?
    Hoferová Z; Vacek A; Hofer M; Macková NO; Soucek K; Egyed A; Fedorocko P
    Cancer Invest; 2003 Apr; 21(2):227-36. PubMed ID: 12743988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thermochemotherapy-induced resistance to cyclophosphamide.
    Urano M; Kahn J; Kenton LA
    Br J Cancer; 1988 Mar; 57(3):295-7. PubMed ID: 3355769
    [No Abstract]   [Full Text] [Related]  

  • 49. Bacteriocins as cytotoxic agents against tumors: the role of possible contaminants.
    Fumarola D
    Boll Ist Sieroter Milan; 1978 Mar; 57(1):101-2. PubMed ID: 656190
    [No Abstract]   [Full Text] [Related]  

  • 50. The Use of Bacteria in Cancer Treatment: A Review from the Perspective of Cellular Microbiology.
    Mills H; Acquah R; Tang N; Cheung L; Klenk S; Glassen R; Pirson M; Albert A; Hoang DT; Van TN
    Emerg Med Int; 2022; 2022():8127137. PubMed ID: 35978704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of bacteria in cancer therapy - enemies in the past, but allies at present.
    Song S; Vuai MS; Zhong M
    Infect Agent Cancer; 2018; 13():9. PubMed ID: 29568324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.
    Arab S; Murakami M; Dirks P; Boyd B; Hubbard SL; Lingwood CA; Rutka JT
    J Neurooncol; 1998 Nov; 40(2):137-50. PubMed ID: 9892096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.
    Farkas-Himsley H; Hill R; Rosen B; Arab S; Lingwood CA
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6996-7000. PubMed ID: 7624357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
    Teicher BA; Holden SA; Ara G; Northey D
    Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma.
    Hill RP; Farkas-Himsley H
    Cancer Res; 1991 Mar; 51(5):1359-65. PubMed ID: 1997173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.